These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6439485)

  • 1. A study of antibacterial activity of furbenicillin against beta-lactamase producing gram-negative organisms.
    Yang YJ; Li JT
    Chin Med J (Engl); 1984 May; 97(5):345-51. PubMed ID: 6439485
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identification of beta-lactamases of gram-negative bacteria and antibacterial activity of furbenicillin to this strain of bacteria].
    Li JT; Yang YJ
    Zhonghua Yi Xue Za Zhi; 1984 Aug; 64(8):486-9. PubMed ID: 6440695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of mecillinam against ESBL producers in vitro.
    Thomas K; Weinbren MJ; Warner M; Woodford N; Livermore D
    J Antimicrob Chemother; 2006 Feb; 57(2):367-8. PubMed ID: 16354745
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.
    Sala A; Chiarino D; Napoletano M; Albini E; Carenzi A
    Farmaco; 1991; 46(7-8):887-97. PubMed ID: 1793473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clavulanic acid as an inhibitor of beta lactamase].
    Dănilă G
    Rev Med Chir Soc Med Nat Iasi; 1981; 85(2):394. PubMed ID: 6981154
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
    Campos M; Alarcón MA; González H; Sánchez R
    Microbios; 1993; 76(308):171-9. PubMed ID: 8302198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
    Zhao WH; Asano N; Hu ZQ; Shimamura T
    J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapid determination of the synergy of clavulanic acid and beta lactams by measuring the intracellular ATP by bioluminescence].
    Cornel E; Philippon A; Paul G; Guenounou M
    Ann Microbiol (Paris); 1982; 133(3):365-77. PubMed ID: 6819796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-lactamase inhibitors and their possible therapeutic significance].
    Fomina IP; Lobuseva AN; Navashin SM
    Antibiotiki; 1984 Feb; 29(2):142-8. PubMed ID: 6367631
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
    Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of extended-spectrum beta-lactamase (ESBL)-producing organisms in blood culture.
    Weinbren MJ; Borthwick MA
    J Antimicrob Chemother; 2005 Jan; 55(1):131-2. PubMed ID: 15574477
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clavulanic acid sulbactam on induction of class 1 beta-lactamase.
    Farmer TH; Reading C
    J Chemother; 1989 Jul; 1(4 Suppl):331-3. PubMed ID: 16312426
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.